N/A N=62 LoViReT (Low Viral Reservoir Treated Patients)
Hiv
Primary: Longitudinal Analysis of Total HIV DNA and Immune-phenotype by Digital Droplet Polymerase Chain Reaction (PCR) and Flow Cytometry, Respectively, Comparing This Outcome…
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=200 A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
Atopic Dermatitis
Primary: Number of Participants With Adverse Events (AEs) and Serious AEs (SAEs): Main Study — 30; 26; 0; 1 Participants
N/A N=12 Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
Glioblastoma
Primary: Number of Participants With Ketosis — 9 Participants
Phase 1 N=24 A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants
HIV Infections
Primary: Number of Participants With Grade 2 or Higher (>=) Adverse Events (AEs) Following SC Administration of VH3810109 (Part 1 and Part 3) — 7; 8 Participants
N/A N=30 Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma
Colorectal Carcinoma
Primary: Feasibility of Physical Activity After 12 Weeks (3 Months) — 331 Participant-weeks
Phase 4 N=48 Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Pain, Postoperative · Urethral Stricture
Primary: Participant Pain Control: Numerical Rating Scale (NRS) — 1.2; .625 score on a scale
N/A N=199 Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis
Dialysis
Primary: ED Visits and Hospitalizations — 0.244; 0.287 cases per person-months
Phase 3 N=450 A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)
Atherosclerotic Cardiovascular Disease
Primary: Percent Change From Baseline in LDL-C — -60.0; -7.0 percent change in LDL-C — p=<0.001
Phase 1 N=22 A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
Rheumatoid Arthritis · Psoriatic Arthritis · Crohn's Disease
Primary: Predose and Postdose Plasma Certolizumab Pegol (CZP) Concentrations in Women During Pregnancy, Relative to Postpartum — 15.251; NA; 16.916; 9.027 microgram per…
N/A N=18 Effects of Mindfulness Training on the Psychological Well-being of Preschoolers
Mindfulness-based Intervention for Preschoolers
Primary: Attention and Impulsivity — 50.05; 53.45; 48.32; 56.17 units on a scale
N/A N=159 INcentives and ReMINDers to Improve Long-term Medication Adherence
HIV/AIDS
Primary: Proportion of Pills Taken as Prescribed Over the Intervention Period (Baseline - Month 3) — 0.860; 0.916; 0.914 Proportion of pills taken as prescribed — p=0.056
N/A N=54 tDCS to Decrease Opioid Relapse (UG3)
Opioid Dependence · Craving
Primary: Opioid Craving — 8.92; 8.32 units on a scale — p=.008
Early Phase 1 N=15 Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery
Cesarean Section
Primary: Chloroprocaine Plasma Concentration at 1 Minute — 14.3; 7.5; 3.5 ng/ml
Early Phase 1 N=34 Topical Loperamide Gel for Pain Reduction During Repeat Finger Lancing
Pain
Primary: Pain - Numeric Rating Scale — 2.6; 2.5; 1.9; 4.2 units on a scale — p=0.8
Phase 2 N=14 Reducing Frailty for Older Cancer Survivors Using Supplements
Frailty · Inflammation
Primary: Recruitment Feasibility: Rates of Consent — 0.375 proportion of participants